RY

163.23

+1.83%↑

TD

94.43

+2.23%↑

BMO

137.27

+2.76%↑

CM

95.94

+2.73%↑

BNS

70.16

+2.68%↑

RY

163.23

+1.83%↑

TD

94.43

+2.23%↑

BMO

137.27

+2.76%↑

CM

95.94

+2.73%↑

BNS

70.16

+2.68%↑

RY

163.23

+1.83%↑

TD

94.43

+2.23%↑

BMO

137.27

+2.76%↑

CM

95.94

+2.73%↑

BNS

70.16

+2.68%↑

RY

163.23

+1.83%↑

TD

94.43

+2.23%↑

BMO

137.27

+2.76%↑

CM

95.94

+2.73%↑

BNS

70.16

+2.68%↑

RY

163.23

+1.83%↑

TD

94.43

+2.23%↑

BMO

137.27

+2.76%↑

CM

95.94

+2.73%↑

BNS

70.16

+2.68%↑

Search

CNO Financial Group Inc

Abrir

SetorFinanças

41.5 2.44

Visão Geral

Variação de preço das ações

24h

Atual

Mín

40.07

Máximo

41.52

Indicadores-chave

By Trading Economics

Rendimento

70M

93M

Vendas

-46M

1.1B

P/E

Médio do Setor

17.171

55.155

EPS

1.47

Rendimento de Dividendos

1.69

Margem de lucro

8.127

Funcionários

3,300

EBITDA

-8.3M

165M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+15.31% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.69%

4.95%

Próximos Ganhos

27 de abr. de 2026

Próxima data de dividendos

23 de jun. de 2026

Próxima data de ex-dividendo

9 de jun. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-361M

3.8B

Abertura anterior

39.06

Fecho anterior

41.5

Sentimento de Notícias

By Acuity

54%

46%

353 / 441 Ranking em Finance

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bearish Evidence

CNO Financial Group Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

31 de mar. de 2026, 23:31 UTC

Ações em Alta

Stocks to Watch: Nike, RH, NCino

31 de mar. de 2026, 22:35 UTC

Ganhos

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 de abr. de 2026, 00:00 UTC

Aquisições, Fusões, Aquisições de Empresas

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 de mar. de 2026, 23:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 de mar. de 2026, 23:43 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 de mar. de 2026, 23:33 UTC

Conversa de Mercado
Notícias Principais

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 de mar. de 2026, 23:21 UTC

Ganhos

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 de mar. de 2026, 23:14 UTC

Conversa de Mercado
Ganhos

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 de mar. de 2026, 23:12 UTC

Conversa de Mercado

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 de mar. de 2026, 22:36 UTC

Ganhos

China Vanke 2025 Loss Widens >000002.SZ

31 de mar. de 2026, 22:36 UTC

Ganhos

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 de mar. de 2026, 22:36 UTC

Ganhos

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 de mar. de 2026, 22:36 UTC

Ganhos

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 de mar. de 2026, 22:36 UTC

Ganhos

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 de mar. de 2026, 21:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 de mar. de 2026, 21:36 UTC

Conversa de Mercado

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 de mar. de 2026, 21:35 UTC

Ganhos

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 de mar. de 2026, 21:35 UTC

Ganhos

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 de mar. de 2026, 21:35 UTC

Ganhos

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 de mar. de 2026, 21:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 de mar. de 2026, 21:33 UTC

Ganhos

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 de mar. de 2026, 21:32 UTC

Ganhos

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 de mar. de 2026, 21:28 UTC

Ganhos

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 de mar. de 2026, 21:26 UTC

Ganhos

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 de mar. de 2026, 21:25 UTC

Ganhos

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 de mar. de 2026, 21:24 UTC

Conversa de Mercado
Ganhos

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 de mar. de 2026, 21:22 UTC

Ganhos

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 de mar. de 2026, 21:22 UTC

Ganhos

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 de mar. de 2026, 21:21 UTC

Ganhos

Nike's Digital Channel Still Too Promotional, CFO Says

31 de mar. de 2026, 21:20 UTC

Ganhos

Nike CEO: Converse Remains Important to Portfolio

Comparação entre Pares

Variação de preço

CNO Financial Group Inc Previsão

Preço-alvo

By TipRanks

15.31% parte superior

Previsão para 12 meses

Média 46.33 USD  15.31%

Máximo 50 USD

Mínimo 43 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para CNO Financial Group Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

3 ratings

1

Comprar

1

Manter

1

Vender

Pontuação Técnica

By Trading Central

37.56 / 38.01Suporte e Resistência

Curto Prazo

Very Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bullish Evidence

Sentimento

By Acuity

353 / 441 Ranking em Finanças

Sentimento de Notícias

Evidência de Tendência de Baixa

Volatilidade

Acima da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre CNO Financial Group Inc

CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, insurance products, and financial services for senior and middle-income markets in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individuals through phone, online, mail, and face-to-face. The company also focuses on sale of voluntary benefit life and health insurance products for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed indexed annuities; fixed interest annuities, including fixed rate single and flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. It markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company was founded in 1979 and is headquartered in Carmel, Indiana.
help-icon Live chat